Page last updated: 2024-09-03

exp7711 and tasosartan

exp7711 has been researched along with tasosartan in 2 studies

Compound Research Comparison

Studies
(exp7711)
Trials
(exp7711)
Recent Studies (post-2010)
(exp7711)
Studies
(tasosartan)
Trials
(tasosartan)
Recent Studies (post-2010) (tasosartan)
18012568

Protein Interaction Comparison

ProteinTaxonomyexp7711 (IC50)tasosartan (IC50)
5-hydroxytryptamine receptor 1AHomo sapiens (human)0.032
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)0.0032
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)0.0032
Type-1 angiotensin II receptorHomo sapiens (human)0.035

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goldberg, MR; Greenlee, WJ; Irvin, JD; Prendergast, K; Smith, RD; Timmermans, PB; Wexler, RR1
Berellini, G; Cruciani, G; Mannhold, R1

Reviews

1 review(s) available for exp7711 and tasosartan

ArticleYear
Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy.
    Journal of medicinal chemistry, 1996, Feb-02, Volume: 39, Issue:3

    Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Humans; Receptors, Angiotensin; Structure-Activity Relationship

1996

Other Studies

1 other study(ies) available for exp7711 and tasosartan

ArticleYear
Pharmacophore, drug metabolism, and pharmacokinetics models on non-peptide AT1, AT2, and AT1/AT2 angiotensin II receptor antagonists.
    Journal of medicinal chemistry, 2005, Jun-30, Volume: 48, Issue:13

    Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Binding Sites; Biphenyl Compounds; Kinetics; Losartan; Models, Molecular; Molecular Conformation; Oxidation-Reduction; Pharmaceutical Preparations; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Structure-Activity Relationship; Tetrazoles

2005